Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgaf672 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Lea Prengemann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pediatric Research, Medical Faculty, University of Leipzig, University Hospital for Children & Adolescents, 04103 Leipzig, Germany. Hauptthemen laut MEDLINE: Infant, Small for Gestational Age, Human Growth Hormone, Insulin Resistance, Insulin. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Research Foundation, Federal Ministry of Research, Technology and Space, German Center for Child and Adolescent Health.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Context
Being born small for gestational age (SGA) and growth hormone (GH) treatment are linked to disturbed glucose-insulin metabolism.
Objective
We investigated how GH treatment affects glucose-insulin metabolism in children born SGA compared to children with isolated growth hormone deficiency (iGHD), obesity and lean controls.
Methods
We analyzed glucose-insulin metabolism indices derived from oral glucose tolerance tests (Matsuda index, AUC insulin) and fasting parameters (fasting glucose, HOMA-IR) in 134 SGA patients without catch-up growth (CUG) receiving GH therapy (SGA-GHT), 27 untreated SGA patients with catch-up growth (SGA-CUG), 308 iGHD patients under GH treatment, 427 children with obesity, and 356 lean controls. We adjusted for sex, age, and BMI through matching and multivariable regression.
Results
Treatment-naïve SGA-GHT patients were more insulin-resistant than iGHD patients (higher insulin AUC [P = .002] and HOMA-IR [P < .001], lower Matsuda index [P < .001]) with levels approaching those of the obesity cohort. Under GH therapy, HbA1c was higher in SGA-GHT and iGHD patients (5.26% ± 0.35 vs 5.25% ± 0.25) than in lean controls (5.09% ± 0.27). Insulin resistance in SGA-GHT patients approached levels seen in obesity. Prediabetes prevalence was highest in SGA-GHT children (11.11%) compared to those with iGHD (1.59%) or obesity (3.13%). After stopping GH therapy, SGA-GHT patients retained elevated markers of prediabetes (4.65%) and insulin resistance compared to controls and iGHD patients, similar to children with obesity (6.38%). No overt type 2 diabetes was observed.
Conclusion
SGA patients have an impaired glucose-insulin metabolism similar to that of children with obesity, which worsens under GH therapy. Close metabolic monitoring of GH-treated SGA patients is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pediatric Research, Medical Faculty, University of Leipzig, University Hospital for Children & Adolescents, 04103 Leipzig, Germany.
- Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, 04103 Leipzig, Germany.
- German Center for Child and Adolescent Health (DZKG), Partner Site Leipzig/Dresden, 04103 Leipzig, Germany.
- Leipzig Center of Metabolism (LeiCeM), Medical Faculty, University of Leipzig, 04103 Leipzig, Germany.
- LIFE-Leipzig Research Center for Civilization Diseases, University of Leipzig, 04103 Leipzig, Germany.
- Leipzig Reproductive Health Research Center (LE-REP), Leipzig University, 04103 Leipzig, Germany.
ORCID-Profile: Robert Stein, Ruth Gausche, Christoph Beger, Mandy Vogel, Wieland Kiess, Antje Körner
Förderung
- German Research Foundation
- Federal Ministry of Research, Technology and Space
- German Center for Child and Adolescent Health
- Hexal
- NovoNordisk
- Biomarin
- German Diabetes Association
- University Leipzig
Zitieren
APA
Prengemann, L., Stein, R., Gausche, R., Beger, C., Vogel, M., Wenzel, E., Stoltze, A., Kiess, W., Pfäffle, R., & Körner, A. (2026). Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf672
Vancouver
Prengemann L, Stein R, Gausche R, Beger C, Vogel M, Wenzel E, et al. Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf672
BibTeX
@article{Prengemann2026,
author = {Prengemann, Lea and Stein, Robert and Gausche, Ruth and Beger, Christoph and Vogel, Mandy and Wenzel, Eric and Stoltze, Anette and Kiess, Wieland and Pfäffle, Roland and Körner, Antje},
title = {Children born SGA receiving growth hormone have similarly impaired glucose-insulin metabolism as children with obesity},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgaf672}
}
EUVIMED